Autoimmune hemolytic anemia in systemic lupus erythematosus: association with thrombocytopenia.
Hematological disturbances are common in systemic lupus erythematous (SLE). Specifically, autoimmune hemolytic anemia (AHA) may manifest in SLE patients at the time of diagnosis or within the first year of the disease. AHA is often associated with thrombocytopenia, lupus nephritis, and central nervous system activity. In this study we investigated these associations in Brazilian patients with SLE. Forty-four consecutive SLE patients who had a history of AHA were age, gender, and disease duration matched with 318 SLE patients without AHA who formed the control group. All patients fulfilled the revised American College of Rheumatology criteria for SLE and were followed-up within our Service. Clinical and laboratorial manifestations were similar in both groups, except for the predominance of leukopenia, thrombocytopenia, and anti-dsDNA on univariate analysis in the AHA group. The multivariate logistic regression model revealed risk only for thrombocytopenia in the AHA group compared to the control group (odds ratio, 2.70; 95% confidence interval, 1.32-5.50). Our results corroborate previous data that AHA in SLE increases the risk of thrombocytopenia in individuals with SLE. This association suggests a common mechanism in AHA and SLE pathophysiologies.
Domiciano
Diogo Souza
DS
Division of Rheumatology, Faculdade de Medicina da Universidade de São Paulo, Av. Dr. Arnaldo, 455, Sala 3190, 3° andar, CEP 01246-903 São Paulo, Brazil.
Shinjo
Samuel Katsuyuki
SK
D000328:Adult; D000744:Anemia, Hemolytic, Autoimmune / Q000097:blood / Q000150:complications* / Q000453:epidemiology; D001938:Brazil / Q000453:epidemiology; D005260:Female; D006801:Humans; D008180:Lupus Erythematosus, Systemic / Q000097:blood / Q000150:complications* / Q000453:epidemiology; D008297:Male; D008875:Middle Aged; D012189:Retrospective Studies; D013921:Thrombocytopenia / Q000097:blood / Q000150:complications* / Q000453:epidemiology
Rheumatology (Oxford). 2003 Feb;42(2):230-4
12595615
J Rheumatol. 1993 Feb;20(2):400-1
8474087
Am J Med. 2000 Feb 15;108(3):198-204
10723973
Pathology. 2004 Apr;36(2):129-38
15203748
J Clin Invest. 1993 Apr;91(4):1672-80
8473510
Arthritis Rheum. 2008 Sep 15;59(9):1332-40
18759263
Ann Rheum Dis. 1962 Dec;21:360-9
14012863
Immunol Lett. 2003 Aug 5;88(2):95-9
12880676
J Lab Clin Med. 1990 Jan;115(1):74-88
1688911
Clin Lab Med. 2002 Jun;22(2):447-74
12134471
Proc Natl Acad Sci U S A. 1990 Aug;87(15):5734-8
1696010
Lupus. 2008 Aug;17(8):739-43
18625652
Blood. 2003 Feb 1;101(3):992-7
12393658
Arthritis Rheum. 2004 Dec 15;51(6):1030-44
15593352
Ann Intern Med. 1977 Feb;86(2):220-9
835948
Braz J Med Biol Res. 1994 Mar;27(3):637-43
8081288
Scand J Rheumatol Suppl. 1975;11:12-9
56774
AMA Arch Intern Med. 1951 Jan;87(1):48-65
14782741
Medicine (Baltimore). 2006 May;85(3):147-156
16721257
Ann Rheum Dis. 2006 Feb;65(2):144-8
16079164
Arthritis Rheum. 1997 Sep;40(9):1725
9324032
Lupus. 1997;6(8):652-5
9364424
J Rheumatol. 1989 Jul;16(7):926-30
2769665
Br J Rheumatol. 1992 Jul;31(7):453-5
1628167
Arthritis Rheum. 1987 Apr;30(4):382-8
3107577
Clin Rheumatol. 1998;17(6):468-77
9890674